The Evidence Generation Manager provides scientific leadership and end-to-end accountability for Local Evidence Planning (LEP) and execution, including Real World Evidence (RWE) and local clinical studies.
This role ensures alignment between global evidence strategies (GMA) and local regulatory, access, and clinical practice needs, driving high-impact evidence generation to support decision-making and improve patient outcomes.
Major accountabilities:
1. Integrated Evidence Planning (IEP) – global to local adaptation
Co-build and adapt Global Integrated Evidence Plans (IEPs) to local market context, including regulatory requirements, access and reimbursement needs, clinical practice environment
Identify and prioritize country-specific evidence gaps based on stakeholder needs and product strategy
Ensure alignment between global evidence strategy and local execution plans
Continuously assess and refine evidence priorities based on emerging data and insights
2. Local Evidence Planning, Execution Oversight, and Leadership
Lead and oversee end-to-end Local Evidence Plan (LEP) execution, translating strategy into actionable studies with cross-functional alignment
Provide strategic oversight of evidence generation activities, ensuring consistency with LEP priorities
Maintain and continuously refine the Taiwan LEP framework to ensure adaptability to evolving environmental and business needs
Lead local clinical studies and RWE across the full lifecycle, including design, execution, analysis, and result interpretation
3. External Collaboration & Evidence Co-creation
Establish and maintain collaborations with medical experts, investigators and academic institutions, external stakeholders
Explore data partners to expand local real-world data source
Ensure external insights are integrated into evidence strategy and study design
Timely and accurate handling of internal and external statistical inquiries
4. Innovation & Advanced Evidence Generation
Drive adoption of innovative evidence generation approaches, including advanced RWD methodologies and novel study designs
Leverage AI and emerging data technologies, to enhance efficiency, quality, and impact of evidence generation
Promote continuous improvement of data-driven and innovative evidence generation capabilities
5. Global Alignment & Governance
Ensure strong alignment with Global Medical Affairs – Evidence Generation (GMA) strategies, processes, and governance
Ensure all activities comply with Novartis SOPs, GCP and regulatory requirements
Maintain inspection readiness and documentation integrity
Requirement
Advanced degree in Life Sciences, Epidemiology, Biostatistics, or related field
3+ years of RWE experience using healthcare databases or EMR in industry, consulting, or CRO
Strong communication and interpersonal skills
Strong expertise in study design, protocol writing and methodology
Demonstrated ability to work collaboratively with cross-functional teams.
Ability to leverage AI and data-driven tools
Knowledge / experience with SAS/ R/ S plus or any other business or research analytic software.
Understanding of multivariable models (cox, poisson, binomial and multinomial logistic, ANOVA and MANOVA and multivariate approach. (cluster discriminant, factor analysis)
Relevant medical/ clinical background
Fluent in English & Mandarin (oral and written)
Skills Desired
Clinical Research, Clinical Trials, Drug Development, Internal Control, Organization Skills, Stakeholder Engagement

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Find out more at https://www.novartis.com
See our community guidelines: https://go.novartis.social/3Nboxki